Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test

American Journal of Cardiology

Volumn 78, Issue 5, 1996, Pages 536-539

  Sheldon, Robert ^a,b   Rose, Sarah ^a   Flanagan, Patricia ^a   Koshman, Mary Lou ^a   Killam, Shawn ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Calgary General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIAGNOSTIC AGENT; ISOPRENALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RECURRENT DISEASE; SYNCOPE; TILT TABLE TEST; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; RECURRENCE; SYNCOPE; TILT-TABLE TEST; TREATMENT OUTCOME;

EID: 0030237282     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00359-1     Document Type: Article

References (30)

1. Almquist A, Goldenberg IF, Milstein S, Chen MY, Chen X, Hansen R, Gornick GC, Benditt DG. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-351.
2. Abi-Samra F, Malony JD, Fouad-Tarazi FM, Castle LW. The usefulness of head-up tilt testing and hemodynamic investigations in the work-up of syncope of unknown origin. PACE 1988;11:1202-1214.
3. Waxman MB, Yao L, Cameron DA, Wald RW, Roseman J. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 1989;63:58-65.
4. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989;1:658-660.
5. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Multivariate predictors of syncope recurrence in drugfree patients following a positive tilt test. Circulation 1996;93:973-981.
6. 2-adrenergic receptors. Circulation 1994;89:2401-2411.
7. Lipsitz LA, Marks ER, Koestner J, Jonsson PV, Wei JY. Reduced susceptibility to syncope during postural tilt in old age. Is β-blockade protective? Arch Int Med 1989;149:2709-2712.
8. Mitchell LB, Wyse DG, Duff HJ. Programmed electrical stimulation studies of ventricular tachycardia in humans. The role of ventricular functional refractoriness in tachycardia induction. J Am Coll Cardiol 1986;8:567-575.
9. Sheldon RS, Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 1992;19:773-779.
10. Sheldon R. Evaluation of a single-stage isoproterenol-tilt table test in patients with syncope. J Am Coll Cardiol 1993;22:114-118.
11. Cook DJ, Guyatt GH, Laupacis A, Sachett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992;102:305S-311S.
12. Sheldon R. Tilt table testing in the diagnosis and treatment of syncope. Cardiovasc Rev Rep 1994;8-28.
13. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991;44:1037-1043.
14. Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB. Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Int Med 1994;9:181-186.
15. Pritchett ELC, Lee KL. Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias. J Clin Epidemiol 1988;41:851-858.
16. Greer SG, Wilkinson WE, McCarthy EA, Pritchett ELC. Random and nonrandom behavior of symptomatic paroxysmal atrial fibrillation. Am J Cardiol 1989;64:339-342.
17. Malik P, Koshman, Sheldon RS. Time to first syncopal spell following tilt table test predicts number of recurrent spells (Abstract). Circulation 1995;92:I-414.
18. Sra JS, Anderson AJ, Sheikh SH, Avitall B, Tchou PJ, Troup PJ, Gilbert CJ, Akhtar M, Jazayeri MR. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Int Med 1991;114:1013-1019.
19. Sra JS, Murthy VS, Jazayeri MR, Shen YH, Troup PJ, Avitall B, Akhtar M. Use of intravenous esmolol to predict efficacy of oral β-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1992;19:402-408.
20. Morillo C, Leitch J, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-1848.
21. Moya A, Permanyer-Miraldo G, Sagrista-Savleda J, Carne X, Rius T, Mont L, Soler-Soler J. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine verus placebo. J Am Coll Cardiol 1995;25:65-69.
22. Grubb BP, Temesy-Armos P, Hahn H, Elliott L. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. Am J Med 1991;90:6-10.
23. Fitzpatrick AP, Ahmed R, Williams S, Sutton R. A randomised trial of medical therapy in "malignant vasovagal syndrome" or "neurally-mediated 7 bradycardia/hypotension syndrome". Eur J Card Pacing Electrophysiol 1991;2:99-102.
24. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70:339-342.
25. Cox MM, Perlman BA, Mayor MR, Silberstein TA, Levin E, Pringle L, Castellanos A, Myerburg R. Acute and long-term β-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995;26:1293-1298.
26. Cohen MB, Snow JS, Grasso V, Lehnert L, Goldner BG, Jadonath RL, Cohen TJ. Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 1995;13:780-790.
27. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995;130:1250-1253.
28. Abe H, Kobayashi H, Nakashima Y, Izumi F, Kuroiwa A. Effects of β-adrenergic blockade on vasodepressor reaction in patients with vasodepressor syncope. Am Heart J 1994;128:911-918.
29. Leor J, Rotstein Z, Vered Z, Kaplinsky E, Truman S, Eldar M. Absence of tachycardia during tilt test predicts failure of β-blocker therapy in patients with neurocardiogenic syncope. Am Heart J 1994;127:1539-1543.
30. Lippman N, Stein KM, Lerman BB. Differential therapeutic responses of patients with isoproterenol-dependent and isoproterenol-independent vasodepressor syncope. Am Heart J 1994;128:1110-1116.